• peji - 1

Kurapa kushandisa nyanzvi Typhoid Test kit, nhanho imwe nekukurumidza bvunzo kaseti

Tsanangudzo Pfupi:


Product Detail

Product Tags

Clinical Sensitivity, Kunyatsojeka uye Kururama

Iyo Influenza A+B Antigen Rapid Test yakaedzwa zvichienzaniswa neRT-PCR.539 nasopharyngeal swabs uye oropharyngeal swabs zvakaongororwa neInfluenza A + B Rapid Test.

Zvinhu

Concentration

Zvinhu

Concentration

Nasal Spray

15% v/v

Hemoglobin

10% v/v

Mucin

0.5 % w/v

Mupirocin

10 mg/mL

Nasal Drops

15% v/v

Muromo wekugeza

/

Chloraseptic

1.5 mg/mL

Levofloxacin

40 ug/mL

Oseltamivir

2ug/mL

Ribavirin

0.2ug/mL

Fluticasone propionate

5% v/v

Ceftriaxone

800 ug/mL

Tobramycin

4ug/mL

Saline Nasal Spray

10% v/v

Nefuruwenza A

Nzira

RT-PCR

Total Results

Furuwenza A+B Rapid Test

Results

Positive

Negative

Positive

116

1

117

Negative

5

417

422

Total Results

121

418

539

Clinical senitivity: 95.87% (95% CI: 90.69% ~ 98.22%)
Clinical chaiyo: 99.76% (95% CI: 98.66% ~ 99.96%)
Total coincidence rate:98.89% (95% CI: 97.59% ~ 99.49%).

Nefuruwenza B:

Nzira

RT-PCR

Total Results

Furuwenza A+B Rapid Test

Results

Positive

Negative

Positive

97

1

98

Negative

6

435

441

Total Results

103

436

539

Clinical senitivity: 94.17% (95% CI: 87.87% ~ 97.30%)
Clinical chaiyo: 99.77% (95% CI: 98.71% ~ 99.96%)
Total coincidence rate:98.70% (95% CI: 97.34% ~ 99.37%).

Analytical Sensitivity/LOD

 img-1 Iyo kambani Hangzhou Aichek Medical Technology CO., Ltd.

Jinxing Cun, Yuhang Nharaunda, Yuhang

Dunhu (Ramangwana Sci-Tech Guta), Hangzhou,

Zhejiang, PR China

 img-2 SUNGO Europe BV

Olympisch Stadion 24, 1076DE Amsterdam, Netherlands

Muganho wekuonekwa (LOD) wakaonekwa nekuongorora kwakasiyana siyana kwehutachiona hwefuruwenza A uye hutachiona hwefuruwenza B muInfluenza A+B Antigen Rapid Test.Iwo akatariswa akaonekwa semazinga eLOD akaedzwa akanyorwa pazasi.
Furuwenza A (H3N2): 5×103 TCID50/mL
Furuwenza A (H1N1): 2.5×103 TCID50/mL
Furuwenza A (H1N1 pdm09): 2.5×103 TCID50/mL
Furuwenza B (Yamagata): 3.5×103 TCID50/mL
Influenza B (Victoria): 1.0×103 TCID50/mL

Analytical Specificity (Cross Reactivity)

Kuti uone kutariswa kweiyo Influenza A + B Antigen Rapid Test, akati wandei commensal kana pathogenic microorganisms anogona kunge aripo mupamusoro turakiti rekufema akaedzwa.
Akanaka uye asina kunaka emuenzaniso akapinzwa nema microbes aya akaongororwa pachikamu che106 TCID50/mL, kusanganisira SARS-CoV-2, Human coronavirus HKU1, OC43, NL63, 229E, MERS, Rhinovirus, Adenovirus, Enterovirus, Metapneumotory, Parainflunza, Revrunoviruse syncytial virus, Mycoplasma pneumonia, Chlamydia pneumonia, Streptococcus pneumonia, Staphylococcus aureus, Mycobacterium tuberculosis, Haemophilus influenzae, Streptococcus pyogenes.Hapana kuyambuka-reactivity kwakaonekwa neInfluenza A+B Antigen Rapid Test.

ZVIRI KUSHANDISA

Influenza A+B Antigen Rapid Test is a lateral flow immunoassay yakanangana nemhando yekuongorora furuwenza A uye furuwenza B maantigen mu nasopharyngeal swab uye oropharyngeal swab.

Company Advantage

1.Professional Manufacturer, nyika-yepamusoro-soro tekinoroji "hofori" bhizinesi
2.Deliver zvinhu sechikumbiro chekuraira
3.ISO13485, CE, Gadzirira zvinyorwa zvakasiyana-siyana zvekutumira
4.Reply vatengi mibvunzo mukati maawa 24


  • Zvakapfuura:
  • Zvinotevera:

  • Nyora meseji yako pano uye titumire kwatiri